camrelizumab,albumin-bound paclitaxel
jiangsu hengrui pharmaceuticals
['nsclc', 'sclc', 'ca,022,i', 'ca,022,1', ' cam ', 'cisplatin', 'paclitaxel', 'ca,022,001', 'thoracic', 'albumin,bound,paclitaxel', 'lung', 'camrelizumab']
new io plus chemo combination for nsclc in neo adjuvant setting. camrelizumb plus chemo vs chemo . phase 2 trial . a new option. is it better than others ? #esmoimmuno22 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists